Joshua Lehrer-Graiwer
Nessuna posizione attualmente
Patrimonio netto: 3 M $ in data 31/05/2024
Storia della carriera di Joshua Lehrer-Graiwer
Precedenti posizioni note di Joshua Lehrer-Graiwer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| LENZ THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 19/06/2023 | 21/08/2023 |
| Direttore/Membro del Consiglio | 01/04/2020 | 21/08/2023 | |
| Amministratore Delegato | 01/04/2020 | 21/08/2023 | |
| Direttore Finanziario/CFO | 30/06/2023 | 21/08/2023 | |
| Presidente | 01/04/2020 | 21/08/2023 | |
| GLOBAL BLOOD THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/10/2019 | 17/04/2020 |
| Corporate Officer/Principal | 01/07/2017 | 01/10/2019 |
Formazione di Joshua Lehrer-Graiwer
| University of Cambridge | Graduate Degree |
| Harvard University | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Regno Unito | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
